Systemic corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
- The WISDOM of inhaled corticosteroids in COPD. Halpin, David M. G.; Quint, Jennifer K. // Thorax;Dec2014, Vol. 69 Issue 12, p1071
The article focuses on a study showing the effective role of inhaled corticosteroids (ICS) along with bronchodilators in patients with Chronic obstructive pulmonary disease (COPD) reducing the risk of exacerbations. Topics discussed include WISDOM study conducted to investigate the role of ICS,...
- Comparison of the Efficacy of Nebulised Budesonide with Parenteral Corticosteroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Mirici, A.; Meral, M.; Akgun, M. // Clinical Drug Investigation;2003, Vol. 23 Issue 1, p55
Objective: To compare the efficacy and safety of nebulised budesonide and systemic corticosteroid in the treatment of acute exacerbations of chronic obstructive pulmonary disease (COPD). Design: Randomised, double-blind, placebo-controlled, parallel-group trial. Patients and interventions: A...
- Triple therapy benefits COPD patients. // Australian Journal of Pharmacy;Mar2010, Vol. 91 Issue 1078, p78
The article reports on the study which reveals that combining an anticholinergic with an inhaled corticosteroid and a longacting beta2-agonist may provide clinical benefits in patients with chronic obstructive pulmonary disease.
- Does Inhaled Budesonide Produce Benefits in COPD? Walling, Anne D. // American Family Physician;11/1/1999, Vol. 60 Issue 7, p2156
Presents an evaluation on the treatment of chronic obstructive pulmonary disease (COPD) by inhaled corticosteroids. Long-term effects of inhaled budesonide in patients with COPD; Need for differentiation between asthma and COPD in patients with pulmonary symptoms.
- COPD combo success. // Nature Reviews Drug Discovery;Oct2013, Vol. 12 Issue 10, p728
The article focuses on several drugs for the treatment of chronic obstructive pulmonary disease (COPD), which include the inhaled corticosteroids, long-acting Î²2-adregeneric receptor agonists (LABAs), and long-acting muscarinic receptor antagonists (LAMAs.)
- Inhaled corticosteroid use in patients with COPD or asthma. Kirchner, Jeffrey T. // American Family Physician;5/1/1997, Vol. 55 Issue 6, p2311
Focuses on the chart review conducted by Jackevicius and colleagues to determine the prevalence of inhaled corticosteroid used before and during hospitalization of patients with chronic obstructive pulmonary disease (COPD) or asthma. Methodology used in the study; Most commonly prescribed...
- Step One for Asthma Treatment: Î²-Agonists or Inhaled Corticosteroids? Redington, A.E. // Drugs;Jul2001, Vol. 61 Issue 9, p1231
Inhaled corticosteroids have proven effectiveness in chronic persistent asthma and are now recommended as first-line therapy in this condition. In contrast, long term preventative therapy is not currently considered necessary for patients with disease that is only mild and episodic. Recently,...
- Retraction. // Journal of Clinical Investigation;Dec2014, Vol. 124 Issue 12, p5521
A correction to the article "Denitrosylation of HDAC2 by Targeting Nrf2 Restores Glucocorticosteroid Sensitivity in Macrophages From COPD Patients" by Deepti Malhotra et al. that was published in a 2011 issue is presented.
- Steroid Response in Stable Chronic Obstructive Pulmonary Disease. Mendella, L. A.; Manfreda, J.; Warren, C. P. W.; Anthonisen, N. R. // Annals of Internal Medicine;Jan82, Vol. 96 Issue 1, p17
Compares a two-week course of methylprednisolone with placebo in a double-blind crossover trial in patients with stable chronic obstructive pulmonary disease. Baseline lung function in patients with chronic obstructive pulmonary disease; Criteria for differentiating patients who respond to...